Back to today’s briefing

Story perspectives

Revolutionary Leukemia Drug Offers 97% Success for Kids

7/20/2025

34 5

Summary

Story summary

A groundbreaking leukemia drug, blinatumomab, is revolutionizing care for childhood B-cell acute lymphoblastic leukemia. Four-year-old Madi Seivert, proudly toting her treatment in a flower backpack, symbolizes hope for many. With an impressive success rate of 96-97%, families are optimistic as Madi embarks on the maintenance phase of her journey toward recovery.

1 of 1

Story summary

A groundbreaking leukemia drug, blinatumomab, is revolutionizing care for childhood B-cell acute lymphoblastic leukemia. Four-year-old Madi Seivert, proudly toting her treatment in a flower backpack, symbolizes hope for many. With an impressive success rate of 96-97%, families are optimistic as Madi embarks on the maintenance phase of her journey toward recovery.